These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 6231802

  • 1. Cell-mediated immunity in seronegative spondarthritis treated with levamisole in a double-blind placebo-controlled study.
    Christensen KD, Johnsen HE, Petersen CM.
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):391-5. PubMed ID: 6231802
    [Abstract] [Full Text] [Related]

  • 2. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
    Sansoni P, Rossetti A, Valente G, Butturini U.
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.
    Baron M, Keystone EC, Gladman DD, Lee P, Poplonski L.
    Clin Exp Immunol; 1981 Oct; 46(1):70-6. PubMed ID: 6978216
    [Abstract] [Full Text] [Related]

  • 6. The effect of Levamisole on peripheral blood lymphocyte subpopulations in patients with rheumatoid arthritis and ankylosing spondylitis.
    Rosenthal M, Trabert U, Müller W.
    Clin Exp Immunol; 1976 Sep; 25(3):493-6. PubMed ID: 1085681
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
    Rosenthal M.
    J Rheumatol Suppl; 1978 Sep; 4():97-100. PubMed ID: 366146
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [T-lymphocyte reactivity and the clinical condition of patients with ankylosing spondylitis].
    Sadowska-Wróblewska M, Ryzewska A, Abgarowicz-Miłkowska T, Filipowicz-Sosnowska A, Garwolińska H, Górecka M, Kania A, Miaczyńska-Rusiniak B, Wierzchowska E.
    Reumatologia; 1981 Sep; 19(2):159-67. PubMed ID: 6976607
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Levamisole treatment in ulcus cruris. A double-blind placebo-controlled study.
    Morias J, Peremans W, Campaert H, Mertens RL.
    Arzneimittelforschung; 1979 Sep; 29(7):1050-2. PubMed ID: 387047
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of thymus factor and levamisole treatment in patients with persistent nephrotic syndrome.
    Czekalski S, Sulima D, Strzelecka G.
    Proc Eur Dial Transplant Assoc; 1983 Sep; 19():800-3. PubMed ID: 6603617
    [Abstract] [Full Text] [Related]

  • 17. [In vitro lymphocyte immunoreactivity in sarcoidosis patients. Stimulation with Kveim antigens].
    Tartaglino B, Albera C, Vietti Ramus G, Cesano L.
    Arch Sci Med (Torino); 1982 Sep; 139(2):183-6. PubMed ID: 7138284
    [Abstract] [Full Text] [Related]

  • 18. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study.
    Clegg DO, Reda DJ, Abdellatif M.
    Arthritis Rheum; 1999 Nov; 42(11):2325-9. PubMed ID: 10555027
    [Abstract] [Full Text] [Related]

  • 19. Selective migration of T-cell subset in pleural fluid from non-Hodgkin's lymphoma.
    Gupta S.
    Thymus; 1981 Feb; 2(4-5):277-80. PubMed ID: 7015585
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.